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Abstract
Peptoniphilus spp. are Gram-positive anaerobic cocci (GPAC) that
were formerly classiﬁed in the genus Peptostreptococcus. This study
describes 15 cases of Peptoniphilus spp. bloodstream infection (BSI)
diagnosed from2007 to 2011using 16S rDNAsequencing in patients
with pneumonia, pre-term delivery, soft tissue infection or colon or
bladder disease. Seven out of 15 (47%) of these cases had polymi-
crobial BSIs. One of the isolates was closely related to P. duerdenii
(EU526290),while theother 14 isolatesweremost closely related to
a Peptoniphilus sp. reference strain (ATCC 29743) and P. hareii
(Y07839). Peptoniphilus is a rare but important cause of BSI.
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Gram-positive anaerobic cocci (GPAC) are not routinely
recovered or identiﬁed from many types of clinical specimens
because they may be difﬁcult to grow in culture and are
frequently isolated as part of mixed polymicrobial infections
[1]. Peptoniphilus are commensals of the human vagina and gut
that were formerly classiﬁed in the genus Peptostreptococcus
[2]. Recent implementation of non-biochemical methods
including MALDI-TOF and 16S rDNA sequencing has allowed
their accurate identiﬁcation from a variety of clinical spec-
imens. There are now more than 15 Peptoniphilus species
within the genus, seven of which were discovered in 2012
[3–10]. Several new Peptoniphilus spp. were also recently
discovered as part of a study of the human gut microbiome
in which microbial culturomics was used to complement
genetic analyses [11]. To date, Peptoniphilus spp. have most
commonly been associated with diabetic skin and soft tissue
infections, bone and joint infections and surgical site
infections [12–15]. A recent study of pre-term labour and
early neonatal sepsis also isolated Peptoniphilus spp. from
amniotic ﬂuid causing choramnionitis [16]. To our knowl-
edge, our study is the ﬁrst case series of Peptoniphilus spp.
causing bloodstream infection (BSI) either alone or as part
of a polymicrobial infection.
A retrospective review of all adult patients (>17 years) with
at least one blood culture positive for Peptoniphilus spp. was
carried out. All cases were diagnosed by the regional
centralized clinical microbiology laboratory, Calgary Labora-
tory Services (CLS), between 1 July 2007 and 31 December
2012. The study protocol was approved by the Conjoint
Health Research Ethics Board at the University of Calgary.
All isolateswere recovered fromblood cultures. The regional
protocol for adult blood culture draws routinely collects two
sets, each consisting of both an aerobic (iFA) and anaerobic (iFN)
bottle with incubation, culture and growth monitoring being
performed by the BacT/Alert 3D System (bioMerieux, Laval,
QC, Canada). Positive blood cultures were immediately
pelleted, Gram stained and plated to standard aerobic and
anaerobic culture media. Peptoniphilus spp. isolates demon-
strated typical GPAC morphology on Gram stain from anaer-
obic Brucella blood agar. Prior to 2011, anaerobicGPAC isolates
were preliminarily identiﬁed using antibiotic (KVC) disc testing
and biochemical analysis with the Vitek 2 ANC card (bioMerie-
ux), but subsequently, MALDI-TOF (Vitek MS; bioMerieux) has
been used. Antibiotic susceptibility testing was performed using
E-test strips (bioMerieux) according to CLSI guidelines and the
manufacturer’s instructions [17]. All isolateswere susceptible to
penicillin and metronidazole, and all but one of the isolates (case
#7) was also susceptible to clindamycin.
Preliminary GPAC identiﬁcations were conﬁrmed by per-
forming partial sequencing of the 16S rDNA gene using standard
methods [2,10,18] (ABI Prism 3130 sequencer; Applied Biosys-
tems, Foster City, CA, USA). The SmartGene Integrated
Database Network System (IDNS) indicated the most closely
related species (per cent identity >99%) as shown in Table 1. A
maximum likelihood phylogeny was produced illustrating the
relation of the 15 clinical isolates with publicly available
sequences [19,20].Genus-level identity (99–100%)was achieved
for all 16S rDNA sequences in this study. Species level
identiﬁcation by the IDNS Smartgene database often resulted
in multiple species with >99% sequence similarity. Independent
phylogenetic analysis of the partial 16S rDNA sequences
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conﬁrmed the similarity of CLS sequence KF963596 with
P. duerdenii while the remaining 14 CLS sequences shared
highest similarity with a Peptoniphilus spp. (ATCC 29743). These
sequences were also highly similar (99.6%) to P. harei (Fig. 1).
Patient characteristics and blood culture results are sum-
marized in Table 1. During the study period, 15 hospitalized
patients were diagnosed with Peptoniphilus BSI; nine women
and six men. The mean age was 62 years (range, 20–96 years;
median, 66 years) and the mean length of stay was 18 days
(range, 4–62 days; median, 11 days). BSI due to P. duerdenii
was conﬁrmed in a 34-year-old female with end-stage renal
disease secondary to Goodpasture’s disease and recurrent
pericarditis. All of the other patients with Peptoniphilus spp. BSI
were due to septic abortion with choramnionitis (n = 3), acute
exacerbation of COPD and/or pneumonia (n = 3), skin and
soft tissue infection (n = 2) or underlying bowel and/or
bladder disease (n = 6) (Table 1). Seven (50%) patients had
polymicrobial BSIs with other bacteria besides Peptoniphilus
spp., including (i) Aerococcus urinae, (ii) Escherichia coli, (iii)
Group B Streptococcus, (iv) Eggerthella lenta, (v) Bacteroides
fragilis and viridians streptococcus group, (vi) Proteus mirabilis
and Staphylococcus aureus, and (vii) Enterococcus faecalis. Most
polymicrobial BSIs originated from a bowel or bladder source,
except for one patient with diabetes mellitus and severe
necrotizing infection of the leg, and one elderly patient with
aspiration pneumonia.
Only one of the three women with Peptoniphilus BSI
secondary to septic abortion/choramnionitis was discharged
home with a live infant. Three of 15 (20%) of the patients died,
and all of them were elderly with signiﬁcant underlying
co-morbidities. All of the other patients with Peptoniphilus
BSI were successfully treated with antibiotics and discharged
from hospital.
Peptoniphilus spp. would typically be recovered as a com-
ponent of mixed bacterial ﬂora in complex abscesses in the
abdomen or pelvis. We would therefore expect to recover
Peptoniphilus spp. as part of a polymicrobial BSI infection in
patients with underlying bowel or bladder disease as occurred
in our study. The recovery of Peptoniphilus alone indicates that
this organism is a rare but important cause of BSI as a primary
pathogen in certain clinical settings (i.e. septic abortion, soft
tissue infection in immunocompromised patients and pneu-
monia).
Sequencing of the 16S rDNA gene is a valuable tool for
deﬁnitive molecular identiﬁcation of important clinical isolates
that cannot be readily identiﬁed by phenotypic methods or
MALDI-TOF [21]. Peptoniphilus spp. are often misidentiﬁed
using biochemical methods [22], and MALDI-TOF databases
currently do not include most species. Most of our isolates had
highly similar sequences to a reference Peptoniphilus spp. strain
that has been called P. assacharolyticus ATCC 29743 (GenBank
DQ986463). However, it is clear from our phylogenetic
FIG. 1. Maximum likelihood phylogeny of partial 16S rDNA (variable regions V1–V3) sequences from the Peptoniphilus BSI isolates (GenBank
accessions KF963582–KF96396) in relation to publicly available Peptoniphilus reference strains (Genbank accession in parentheses). Fasttree 2
software was used to create the tree using the generalized time-reversible nucleotide substitution model [20].
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analysis (Fig. 1) that this reference strain is divergent from the
other typed P. assacharolyticus ATCC 14963 (AF542228), and
most closely related to P. harei (Y07839). Our results support
a previous report of 89.5% 16S rDNA similarity between
P. asaccharolyticus strains ATCC 29743 and ATCC 14963 while
the ATCC 29743 shares 99.4% similarity with P. harei
(Y07839) [22]. We have therefore chosen for now to
designate most of our isolates as Peptoniphilus spp.
In summary, clinical microbiology laboratories should be
aware that Peptoniphilus are rare but important causes of BSI
infection either as the primary pathogen or as part of a
polymicrobial infection. Isolates meeting the preliminary phe-
notypic characteristics for GPAC should be referred for
deﬁnitive identiﬁcation using partial 16S rDNA sequencing.
Delineation of the clinical and epidemiological signiﬁcance and
pathogenic potential of Peptoniphilus spp. in humans is depen-
dent upon further isolates from clinical samples and full
phenotypic and genotypic characterizations.
Nucleotide Sequence Accession Numbers
The sequences of the Peptoniphilus strains described here have
been deposited in GenBank under accession numbers
KF963582–KF963596.
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